Skip to main content
. 2022 Nov 17;13:1259–1270. doi: 10.18632/oncotarget.28310

Table 1. Demographic data of study participants (n = 126).

Genotype
E2− E2+ E4− E4+
Age at enrollment Median (IQR) 64.0 (60–68) 66.0 (62.3–69.8) 66.0 (62.3–69.8) 62.0 (56.5–67.5)
Age at cancer diagnosis Median (IQR) 58.0 (52.4–63.6) 60.6 (58.9–62.4) 59.1 (54.3–63.9) 55.8 (49.8–61.9)
Ethnicity
 Hispanic 3% (3) 0% (0) 3% (3) 0% (0)
 Non-Hispanic 96% (105) 94% (16) 96% (93) 97% (28)
 Decline to answer 1% (1) 6% (1) 1% (1) 3% (1)
Race
 Caucasian/White 89% (97) 94% (16) 90% (87) 90% (26)
 African-American/Black 1% (1) 6% (1) 1% (1) 3% (1)
 Native Hawaiian/Pacific Islander 1% (1) 0% (0) 0% (0) 3% (1)
 American Indian/Alaskan Native 2% (2) 0% (0) 1% (1) 3% (1)
 Asian 2% (2) 0% (0) 2% (2) 0% (0)
 More than 1 race 6% (6) 0% (0) 6% (6) 0% (0)
Highest degree attained
 High school diploma 24% (26) 35% (6) 23% (22) 34% (10)
 Associate/technical 26% (28) 24% (4) 30% (29) 10% (3)
 Undergraduate degree 28% (30) 24% (4) 25% (24) 34% (10)
 Postgraduate degree 23% (25) 18% (3) 23% (22) 21% (6)
Marital status
 Married/Partnered 60% (65) 47% (8) 56% (54) 66% (19)
 Divorced/Separated 19% (21) 29% (5) 21% (20) 21% (6)
 Widowed 12% (13) 24% (4) 16% (16) 3% (1)
 Single 9% (10) 0% (0) 7% (7) 10% (3)
Employment
 Retired 47% (51) 65% (11) 51% (49) 45% (13)
 Full time 21% (23) 18% (3) 22% (21) 17% (5)
 Part time 20% (22) 12% (2) 18% (17) 24% (7)
 Homemaker 5% (5) 6% (1) 5% (5) 3% (1)
 Unemployed 7% (8) 0% (0) 5% (5) 10% (3)
Total 100% (109) 100% (17) 100% (97) 100% (29)